• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Advanced HIV Disease — Know Your Count: Sponsored by BD

    CD4 testing — still the best measurement to identify advanced HIV disease

    A Devex survey of health professionals globally has identified barriers and opportunities around advanced HIV disease and the use of CD4 cell count testing in efforts to reduce AIDS-related deaths.

    By Devex Partnerships // 06 April 2021
    Click the image above to read the full visual story about using CD4 cell count testing in efforts to reduce AIDS-related deaths

    The COVID-19 pandemic has disrupted the provision of health care around the globe — and, for people living with HIV, has created additional barriers to seeking appropriate care, including the management and prevention of advanced HIV disease, or AHD. A Devex survey of more than 700 health professionals in 90 countries revealed that 90% expect AHD numbers to surge alongside COVID-19, with 42% citing limited access to health care facilities, commodities, and services as major factors.

    The survey, conducted between Nov. 16 and Dec. 11, identified some of the challenges and opportunities around AHD — defined as a CD4 cell count below 200 per cubic millimeter of blood or a World Health Organization clinical stage 3 or 4 event — and the use of CD4 cell count testing as part of the efforts to reduce AIDS-related deaths.

    In its latest guidelines for managing AHD, WHO notes, “CD4 cell count testing at baseline for all people living with HIV remains important,” adding that “Relying on clinical staging alone risks missing substantial numbers of people living with HIV with severe immune suppression.” While health care professionals agreed that CD4 cell count testing — recommended in the WHO “package of care” — is necessary, many said it was insufficiently implemented.

    Only 55% of respondents said health care practitioners in their countries typically recommend CD4 testing to people newly diagnosed with HIV. Other gaps cited include limited CD4 testing equipment, limited public access to CD4 testing, and a lack of domestic funding as the top barriers to implementation.

    Explore more survey takeaways on advanced HIV disease in this visual story.

    Click the image above to read the full visual story about using CD4 cell count testing in efforts to reduce AIDS-related deaths

    Visit the knowyourcount.devex.com series for more coverage on how to make diagnostic tests and treatment for advanced HIV patients more accessible by sharing insights from practitioners, policymakers, and people living with AHD. You can join the conversation using the hashtag #AdvancedHIV.

    • Global Health
    • Research
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Devex Partnerships

      Devex Partnerships

      Thanks for reading and for your interest in Devex. In collaboration with our partners, Devex’s partnerships editorial team produces content to promote a partner’s work or perspectives on a particular issue. It gives actors across the global development sector — including nongovernmental organizations, private sector stakeholders, aid agencies and government institutions — the opportunity to go beyond traditional advertising and tell their stories in an impactful way. If you’d like to learn more about how you can shine a spotlight on a particular issue with Devex, please email partnerships@devex.com. We look forward to hearing from you.

    Search for articles

    Most Read

    • 1
      Exclusive: A first look at the Trump administration's UNGA priorities
    • 2
      Opinion: AI-powered technologies can transform access to health care
    • 3
      WHO anticipates losing some 600 staff in Geneva
    • 4
      AIIB turns 10: Is there trouble ahead for the China-backed bank?
    • 5
      Opinion: Resilient Futures — a world where young people can thrive
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement